Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications. The New Zealand dental journal. [N Z Dent J] Journal article

Title	Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Author(s)	Hay KD, Bishop PA
Institution	Oral Health Regional Service, Green Lane Clinical Centre, Auckland. dhay@adhb.govt.nz
Source	N Z Dent J 2006 Mar; 102(1):4-9.
MeSH	Adenocarcinoma Aged, 80 and over Bone Density Conservation Agents Carcinoma Diabetes Mellitus, Type 2 Diphosphonates Female Follow-Up Studies Humans Imidazoles Male Mandibular Diseases Maxillary Diseases Middle Aged Multiple Myeloma Osteonecrosis Patient Care Planning Tooth Extraction
Abstract	Bisphosphonates are drugs of choice in the management of a variety of bone disorders including osteoporosis, Paget's disease and bone cancer. Recently there have been increasing reports of a possible relationship between bisphosphonate therapy and osteonecrosis of the jaws. Osteonecrosis may occur following extractions or dental surgery and, in some cases, may appear spontaneously. Because of the potentially serious nature of these complications and the failure of exposed bone to heal, dentists must be aware of recommended precautions for the management of patients taking bisphosphonate medication.
Language	eng
Pub Type(s)	Case Reports Journal Article
PubMed ID	16568881

Advertise on this site.